JP2024500360A5 - - Google Patents
Info
- Publication number
- JP2024500360A5 JP2024500360A5 JP2023535468A JP2023535468A JP2024500360A5 JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5 JP 2023535468 A JP2023535468 A JP 2023535468A JP 2023535468 A JP2023535468 A JP 2023535468A JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- polymerosomes
- seq
- peo
- populations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20213488.8 | 2020-12-11 | ||
| EP20213488 | 2020-12-11 | ||
| PCT/EP2021/085366 WO2022123070A1 (en) | 2020-12-11 | 2021-12-13 | Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500360A JP2024500360A (ja) | 2024-01-09 |
| JP2024500360A5 true JP2024500360A5 (enExample) | 2024-07-11 |
Family
ID=74187071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535468A Pending JP2024500360A (ja) | 2020-12-11 | 2021-12-13 | 関連づけられた抗原および関連づけられたアジュバントを有する２つのポリマーソーム集団を投与することによる、Ｔｈ１／Ｔｈ２免疫応答の調整方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230398207A1 (enExample) |
| EP (1) | EP4259197A1 (enExample) |
| JP (1) | JP2024500360A (enExample) |
| AU (1) | AU2021396659A1 (enExample) |
| CA (1) | CA3193643A1 (enExample) |
| WO (1) | WO2022123070A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104936579B (zh) * | 2012-11-19 | 2020-02-07 | 新加坡科技研究局 | 用于引发对免疫原的免疫响应的方法 |
| CN120641124A (zh) * | 2022-10-21 | 2025-09-12 | Pds生物科技公司 | 用对映特异性阳离子脂质r-dotap配制的重组蛋白疫苗及其使用方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| EP2281033B1 (en) | 2008-04-17 | 2014-10-15 | Vin de Bona Trading Co Pte | Post release modification of viral envelopes |
| US8323696B2 (en) | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
| CN102460150B (zh) | 2009-04-20 | 2015-05-20 | 新加坡科技研究局 | 囊泡系统及其用途 |
| EP2601262A4 (en) | 2010-08-05 | 2014-01-22 | Agency Science Tech & Res | VESIGN STRUCTURE WITH SEVERAL CHAMBERS AND METHOD FOR THEIR EDUCATION |
| EP4218808A3 (en) | 2012-03-12 | 2023-08-09 | Advanced BioAdjuvants, LLC | Adjuvant and vaccine compositions |
| DK2906717T3 (en) | 2012-10-11 | 2019-04-01 | Vin De Bona Trading Company Pte Ltd | PROCEDURE FOR PAINTING MICROVESICS |
| CN104936579B (zh) | 2012-11-19 | 2020-02-07 | 新加坡科技研究局 | 用于引发对免疫原的免疫响应的方法 |
| UA130246C2 (uk) * | 2013-09-19 | 2025-12-31 | Зоетіс Сервісіз Ллс | Ад'ювант на основі олії |
| EP2898894A1 (en) | 2014-01-27 | 2015-07-29 | LTS LOHMANN Therapie-Systeme AG | Nano-in-micro particles for intradermal delivery |
| US9636397B2 (en) | 2015-03-24 | 2017-05-02 | VaxLiant, LLC | Adjuvant compositions and related methods |
| US10696985B1 (en) * | 2016-06-06 | 2020-06-30 | Vanderbilt University | Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery |
| WO2019145475A2 (en) * | 2018-01-25 | 2019-08-01 | Acm Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof |
| BR112022001185A2 (pt) * | 2019-08-01 | 2022-03-15 | Acm Biolabs Pte Ltd | Método de eliciamento de uma resposta imune administrando uma população de polimerossomos tendo um antígeno associado com uma população de polimerossomos tendo um adjuvante associado, bem como composições compreendendo as duas populações de polimerossomos |
| WO2021214339A2 (en) * | 2020-04-24 | 2021-10-28 | Acm Biolabs Pte Ltd | Vaccine against human-pathogenic coronaviruses |
-
2021
- 2021-12-13 JP JP2023535468A patent/JP2024500360A/ja active Pending
- 2021-12-13 WO PCT/EP2021/085366 patent/WO2022123070A1/en not_active Ceased
- 2021-12-13 US US18/256,896 patent/US20230398207A1/en active Pending
- 2021-12-13 EP EP21836471.9A patent/EP4259197A1/en active Pending
- 2021-12-13 AU AU2021396659A patent/AU2021396659A1/en active Pending
- 2021-12-13 CA CA3193643A patent/CA3193643A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543038A5 (enExample) | ||
| US20080124350A1 (en) | Nanoparticle-based vaccine delivery system containing adjuvant | |
| Scott et al. | IL-12 as an adjuvant for cell-mediated immunity | |
| US6359054B1 (en) | Polynucleotide compositions for intramuscular administration | |
| CN114728154A (zh) | 基于丝素蛋白的微针及其用途 | |
| Yang et al. | Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori | |
| TR201904758T4 (tr) | İmmünoterapiye yönelik RNA formülasyonu. | |
| KR20050009697A (ko) | 올리고뉴클레오티드 조성물 및 면역 반응 조절시 이의 용도 | |
| JP2024500360A5 (enExample) | ||
| JP2021512142A5 (enExample) | ||
| CN112118847A (zh) | 包含突变kras序列和脂质的化合物及其用途 | |
| US9750692B2 (en) | Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant | |
| US7256180B2 (en) | Compositions and methods for inducing activation of dendritic cells | |
| Hassan et al. | From antigen uptake to immune modulation: The multifaceted potential of peptide nanofibers as vaccine nanocarriers | |
| CN118055775A (zh) | 包括hsp90抗原肽的抗癌用疫苗组合物及其用途 | |
| US20250235532A1 (en) | Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof | |
| US20250170236A1 (en) | A novel cationic adjuvant composition | |
| WO2001083698A2 (en) | Compositions and methods for inducing activation of dendritic cells | |
| CN120769913A (zh) | 基于核酸的癌症疫苗及其方法 | |
| US20220370488A1 (en) | Mucus penetrating particle compositions and methods of use thereof enhancing immune response | |
| Khan et al. | Nanovaccines against viral infections: Current trends and future prospects | |
| TW202108169A (zh) | 裝載抗原決定位與佐劑之奈米粒子之疫苗、其製備方法及中和病毒感染方法 | |
| KR102901149B1 (ko) | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 | |
| WO2024186623A1 (en) | Methods of making dried pharmaceutical compositions | |
| US20240181070A1 (en) | Nanovaccines for treatment of viral diseases |